in this issue
Regions :: Western Europe :: U.K.
Reckitt Benckiser continuing to review pharma options
10:51 AM MST | February 12, 2014 | Natasha Alperowicz
Consumer goods group Reckitt Benckiser (Slough, UK) today announced its quarterly and annual results and said that it is still reviewing the future of its pharmaceuticals business. Fourth-quarter sales were 5% higher at constant exchange rates, at £2.5 billion ($4.1 billion). Quarterly profits have not been disclosed. Full-year 2013 net income was down 5%, to £1.74 billion, on 5% higher sales, at £10 billion. “Our strategy for growth and outperformance through driving health and hygiene power brands together with our focus on 16 power...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee